Metavate 1gm Tablet is used to prevent or treat peptic ulcers or gastrointestinal ulcers. A peptic ulcer is a sore on the stomach's lining or the first part of the small intestine (duodenum). An ulcer or sores of the stomach region is called a gastric ulcer, while an ulcer of the duodenum is known as a duodenal ulcer.

Metavate 1gm Tablet contains 'Sucralfate', which works by forming a protective barrier or coat over the ulcer so that digestive enzymes, acid and bile salts cannot further irritate the lining of the stomach and duodenum. This protects the ulcer from the stomach's acid, allowing it to heal.

Your doctor will advise you on how often you take Metavate 1gm Tablet based on your medical condition. Some people may experience common side effects like constipation, dizziness, sleepiness, dry mouth, blurred vision, and diarrhoea. Most of these side effects of Metavate 1gm Tablet do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.

Avoid taking any antacid like magnesium hydroxide or aluminium hydroxide within 30 minutes before or after taking Metavate 1gm Tablet. If you are known to be allergic to Metavate 1gm Tablet or active and inactive ingredients present on it, please tell your doctor. If you are pregnant or breastfeeding, it is advised to consult a doctor before using Metavate 1gm Tablet. Duodenal ulcer tends to be a recurrent disease. Try not to stop taking Metavate 1gm Tablet of your own. Stopping a sudden intake of Metavate 1gm Tablet will not influence the frequency or severity of future ulceration. Let your doctor know if you have any kidney problems. People with reduced kidney function may be more likely to experience side effects of aluminium accumulation with Metavate 1gm Tablet. The dose adjustment is necessary for patients with kidney disease and elderly patients.

Metavate 1gm Tablet is used in the treatment of duodenal ulcer. The detailed uses of Metavate 1gm Tablet are as follows:

• Peptic Ulcer Treatment: Metavate 1gm Tablet is commonly used to treat and manage peptic ulcers by forming a protective barrier over the ulcer site, promoting healing.
• Gastroesophageal Reflux Disease (GERD): Metavate 1gm Tablet can help alleviate symptoms associated with GERD by protecting the esophagus from stomach acid.
• Prevention of Ulcer Formation: Metavate 1gm Tablet is often prescribed to prevent the formation of ulcers in patients who require long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs).
• Stomach and Duodenal Ulcer Management: Metavate 1gm Tablet is utilized in managing both stomach ulcers and duodenal ulcers, providing symptomatic relief and promoting healing.
• Mucosal Protection: Metavate 1gm Tablet serves as a mucosal protective agent during therapies that may irritate the gastrointestinal tract, helping to reduce discomfort and damage.

• Metavate 1gm Tablet can be taken with or without food.
• Follow your doctor's instructions on the dosage and timing of this medication.
• Swallow Metavate 1gm Tablet as a whole with a glass of water.
• Do not crush, break, or chew it.

Metavate 1gm Tablet is a class of anti-ulcer drugs prescribed for treating or preventing the return of duodenal ulcers (ulcers located in the first part of the small intestines). Metavate 1gm Tablet works by forming a protective barrier or coat over the ulcer to pepsin and bile and inhibits the diffusion of gastric acid. This protects the ulcer from the stomach's acid, allowing it to heal. Metavate 1gm Tablet exhibits a cytoprotective effect and forms a viscous, adhesive barrier on the surface of the intact intestinal mucosa and the stomach. Metavate 1gm Tablet stimulates the synthesis and release of gastric mucosal prostaglandins, bicarbonate, and the epidermal growth factor, which promotes healing.

You should avoid taking Metavate 1gm Tablet if you are allergic to Metavate 1gm Tablet or other ingredients present in it, have kidney disease, stomach/intestine problems (delayed gastric emptying), are pregnant or planning for pregnancy, and are a breastfeeding mother. Caution is required before giving Metavate 1gm Tablet to elderly patients. Metavate 1gm Tablet contains aluminium, which is normally removed by your kidney. Therefore, older adults and people with kidney problems may be at greater risk for developing high aluminium levels while using this drug with other products containing aluminium (e.g. antacids). The safety and effectiveness in children are not established; please consult your doctor before giving Metavate 1gm Tablet to children.